Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
Particulate matter in parenteral drugs has been recognized as a potential health hazard.
Undefined
Particulate matter in parenteral drugs has been recognized as a potential health hazard.
The Australian Code of Good Manufacturing Practice for human blood and blood components, human tissues and human cellular therapy products 2013 commences on 31 May 2013
On 22 May 2013 the TGA will introduce changes to administrative processes for making minor variations to prescription medicines
Updated information for Appendix 12 and Appendix 13
Incorrect test results at extremely high blood glucose levels.
L’ Agenzia Italiana del Farmaco, in accordo con l’Agenzia Europea dei
Medicinali (EMA), rende disponibile on line nuove ed importanti
informazioni sul potenziale rischio di danno epatico associato a Samsca® (tolvaptan).
Draft compositional guideline for Squid Oil. Closing date: 1 July 2013
Added two products cancelled from the ARTG following compliance review
If a drug product marketed as sterile has microbial contamination, patient is at risk of serious infection.
Patients are at increased risk of infection in the event a sterile product is compromised.
80.211.154.110